Entering text into the input field will update the search result below

BioNTech threatens legal action against CureVac over mRNA vaccine IP spat - Reuters

Jul. 06, 2022 2:13 PM ETBioNTech SE (BNTX), CVACPFEBy: Jonathan Block, SA News Editor5 Comments

Intellectual property law about copyright on desk.

designer491/iStock via Getty Images

  • A day after CureVac (NASDAQ:CVAC) filed an intellectual property infringement suit in a German court against BioNTech (NASDAQ:BNTX), the latter is prepared to take its own legal actions, Reuters reported.
  • The dispute is over technologies

Recommended For You

Comments (5)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

sts66 profile picture

"At the height of the pandemic, it would not have occurred to CureVac to point out patent infringement, but now that there is better control over the pandemic, it believed it was the right time to do so, Haas said."

What a load of horseshite. CVAC also indicated they were eyeballing MRNA for potential IP infringement too - pure money grab that will end up with nobody but the lawyers making any money.

They waited until they had a good idea how much profit was made from the vaccines before they decided to sue. The article suggests they are late to the party with their own vaccine, so whatever they're claiming was stolen from them probably isn't worth much if they weren't able to use it themselves.

Long PFE
Warfare in biowarfare.
Humanity will extinct humanity.
Best defense is a strong offense.

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.